Prostate Cancer - Results from #620

Evaluating recommendation-based dietary and physical activity strategies for prostate cancer prevention: a target trial emulation in the Health Professionals Follow-up Study. July 10, 2024

Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer. July 10, 2024

The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. July 10, 2024

Reducing Prostate Cancer Disparities for Black Men. July 10, 2024

JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression. July 10, 2024

Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer. July 10, 2024

Fluorine-18 Prostate-Specific Membrane Antigen–1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer July 9, 2024

Circulating Tumor Extracellular Vesicles to Monitor Metastatic Prostate Cancer Genomics and Transcriptomic Evolution July 9, 2024

Molecular and diffusion features for identification of clinically significant prostate cancer in PI-RADS 3 lesions. July 9, 2024

A case-cohort study of per- and polyfluoroalkyl substance concentrations and incident prostate cancer in the Cancer Prevention Study-II LifeLink Cohort study. July 9, 2024

Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial. July 9, 2024

Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results Registry. July 9, 2024

Patients' Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER Study. July 9, 2024

Early Prostate Cancer Deaths Among Men With Higher vs Lower Genetic Risk. July 9, 2024

Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer. July 9, 2024

shRNA-mediated gene silencing of HDAC11 empowers CAR-T cells against prostate cancer. July 9, 2024

Predicting prostate cancer grade reclassification on active surveillance using a deep Learning-Based grading algorithm. July 9, 2024

Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer. July 8, 2024

MCTP1 increases the malignancy of androgen-deprived prostate cancer cells by inducing neuroendocrine differentiation and EMT. July 8, 2024

Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models. July 8, 2024

Page 32 of 1436